Astellas Pharma Europe Ltd.
アステラスファーマヨーロッパ株式会社Alias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
7
§01
Basic information
- Head office
- 東京
- Chief executive
- 岡村直樹
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
§02
Websites
§03
Business
Products and Disease AreasRx+事業創成Improvement of Astellas product availabilitySustainability in business activities製品Pipeline
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Avara Norman Pharmaceutical Services, Inc. | ||||||||
| Nippon Medical & Pharmaceutical Co., Ltd. | ||||||||
| OSI Pharmaceuticals, Inc | ||||||||
| Takeda Pharmaceutical Company, Limited | ||||||||
| アステラス ファーマ グローバル ディベロップメント Inc. | ||||||||
| アステラス ファーマ ヨーロッパ B.V. |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
Founded in 1894, Fujisawa Pharmaceutical Industry
Founded in 1923, Yamanouchi Pharmaceutical
Renamed to Yamanouchi Pharmaceutical Co., Ltd. in 1940
Relocated headquarters to Tokyo in 1942
Established in April 2005. Astellas was formed through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical
Established in April 2005. Astellas was formed through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical, and a global strategy centered on patients was shaped.
Celebrated its 20th anniversary in April 2025
Celebrated its 20th anniversary in April 2025.
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain：No
UPDATED2026-10-17 14:56 · Model: ggml-org/gpt-oss-20b